CEO, Path2 Hydrogen AG
Executive Chairman, GenH2
Josh McMorrow serves as the CEO of Path2 Hydrogen AG (FRA:PTHH), a publicly traded company on the Frankfurt Stock Exchange, and as Executive Chairman of GenH2. Josh is a seasoned executive of public and private global companies in industries including hydrogen, industrial gases, energy storage, specialty chemicals and energy production. Josh has led teams on six continents and brings a unique mix of business and legal acumen to bear. Josh guided the $5 billion IPO of Atotech on the NYSE in 2021 as well as the company’s subsequent strategic sale to MKS Instruments in 2022.
With Path2 Hydrogen's acquisition of GenH2 in 2025, the companies are focused on creating a leading pure-play hydrogen public company with essential technology to liquefy, transfer, store, and dispense liquid hydrogen.
Josh has a Bachelor of Science in International Business from Trinity University and holds a J.D., with honors, from The University of Texas School of Law.